JP7205529B2 - オキサゾリジノン化合物の製造方法 - Google Patents
オキサゾリジノン化合物の製造方法 Download PDFInfo
- Publication number
- JP7205529B2 JP7205529B2 JP2020501763A JP2020501763A JP7205529B2 JP 7205529 B2 JP7205529 B2 JP 7205529B2 JP 2020501763 A JP2020501763 A JP 2020501763A JP 2020501763 A JP2020501763 A JP 2020501763A JP 7205529 B2 JP7205529 B2 JP 7205529B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- mol
- mixture
- acetonitrile
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018031603 | 2018-02-26 | ||
JP2018031603 | 2018-02-26 | ||
PCT/JP2019/005969 WO2019163731A1 (ja) | 2018-02-26 | 2019-02-19 | オキサゾリジノン化合物の製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2019163731A1 JPWO2019163731A1 (ja) | 2021-02-04 |
JP7205529B2 true JP7205529B2 (ja) | 2023-01-17 |
Family
ID=67687660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020501763A Active JP7205529B2 (ja) | 2018-02-26 | 2019-02-19 | オキサゾリジノン化合物の製造方法 |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP7205529B2 (zh) |
CN (1) | CN111699184B (zh) |
IL (1) | IL275443B (zh) |
TW (1) | TW201936603A (zh) |
WO (1) | WO2019163731A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7339754B2 (ja) * | 2019-03-27 | 2023-09-06 | ダイト株式会社 | 中間体の製造方法 |
CN111039937B (zh) * | 2019-12-16 | 2021-08-31 | 浙江海翔药业股份有限公司 | 一种利伐沙班中间体的制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005524660A (ja) | 2002-02-25 | 2005-08-18 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | N−アリール−2−オキサゾリジノン−5−カルボキサミドおよびその誘導体ならびに抗細菌剤としてのそれらの使用 |
JP2007517816A (ja) | 2004-01-15 | 2007-07-05 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 製造方法 |
JP2010530385A (ja) | 2007-06-20 | 2010-09-09 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | 置換オキサゾリジノン類およびそれらの使用 |
CN104031036A (zh) | 2014-05-16 | 2014-09-10 | 南通常佑药业科技有限公司 | 一种利伐沙班的制备方法 |
WO2014155259A2 (en) | 2013-03-25 | 2014-10-02 | Glenmark Pharmaceuticals Limited; Glenmark Generics Limited | Process for the preparation of rivaroxaban |
US20150038704A1 (en) | 2012-02-24 | 2015-02-05 | China National Medicines Guorui Pharmaceutical Co. | Method for preparing rivaroxaban intermediate |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016199027A1 (en) * | 2015-06-08 | 2016-12-15 | Mehta Api Pvt. Ltd. | An improved process for preparation of rivaroxaban |
-
2019
- 2019-02-19 CN CN201980012405.8A patent/CN111699184B/zh active Active
- 2019-02-19 IL IL275443A patent/IL275443B/en unknown
- 2019-02-19 WO PCT/JP2019/005969 patent/WO2019163731A1/ja active Application Filing
- 2019-02-19 JP JP2020501763A patent/JP7205529B2/ja active Active
- 2019-02-21 TW TW108105843A patent/TW201936603A/zh unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005524660A (ja) | 2002-02-25 | 2005-08-18 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | N−アリール−2−オキサゾリジノン−5−カルボキサミドおよびその誘導体ならびに抗細菌剤としてのそれらの使用 |
JP2007517816A (ja) | 2004-01-15 | 2007-07-05 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 製造方法 |
JP2010530385A (ja) | 2007-06-20 | 2010-09-09 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | 置換オキサゾリジノン類およびそれらの使用 |
US20150038704A1 (en) | 2012-02-24 | 2015-02-05 | China National Medicines Guorui Pharmaceutical Co. | Method for preparing rivaroxaban intermediate |
WO2014155259A2 (en) | 2013-03-25 | 2014-10-02 | Glenmark Pharmaceuticals Limited; Glenmark Generics Limited | Process for the preparation of rivaroxaban |
CN104031036A (zh) | 2014-05-16 | 2014-09-10 | 南通常佑药业科技有限公司 | 一种利伐沙班的制备方法 |
Non-Patent Citations (1)
Title |
---|
FATTAH, Tanzeela A. et al.,A review on the synthetic approaches of rivaroxaban: An anticoagulant drug,Tetrahedron: Asymmetry,2017年,Vol.28, No.4,pp.485-504,DOI: 10.1016/j.tetasy.2017.02.010 |
Also Published As
Publication number | Publication date |
---|---|
WO2019163731A1 (ja) | 2019-08-29 |
TW201936603A (zh) | 2019-09-16 |
CN111699184A (zh) | 2020-09-22 |
IL275443B (en) | 2022-07-01 |
CN111699184B (zh) | 2023-05-23 |
IL275443A (en) | 2020-08-31 |
JPWO2019163731A1 (ja) | 2021-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4485354B2 (ja) | 新規な置換インドール類 | |
JP4667044B2 (ja) | 5−クロロ−n−({(5s)−2−オキソ−3−[4−(3−オキソ−4−モルホリニル)−フェニル]−1,3−オキサゾリジン−5−イル}−メチル)−2−チオフェンカルボキサミドの製造方法 | |
KR20130004257A (ko) | 제조 방법 | |
JP6325978B2 (ja) | リバロキサバンの製法及び該方法において形成される中間体 | |
JP2015520189A (ja) | ある種の2−(ピリジン−3−イル)チアゾール類の製造方法 | |
SK133198A3 (en) | Piperazine and piperidine compounds, process for their preparation and pharmaceutical compositions containing them | |
JP5827407B2 (ja) | 4−[5−(ピリジン−4−イル)−1h−1,2,4−トリアゾール−3−イル]ピリジン−2−カルボニトリルの製造方法および中間体 | |
JP2014513711A (ja) | チオフェン−2−カルボキサミドを得る方法 | |
EP3168220B1 (en) | Novel method for synthesizing rivaroxaban intermediate, 4-{4-[(5s)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one | |
JP2018513219A (ja) | 縮合環ピリミジンアミノ誘導体、その製造方法、中間体、薬学的組成物及び応用 | |
CA2528093A1 (fr) | Produits aryl-heteroaromatiques, compositions les contenant et utilisation | |
JP2002530276A (ja) | 新規なピペラジンおよびピペリジン化合物 | |
CZ2012114A3 (cs) | Zpusob prípravy rivaroxabanu zalozený na úspore 1,1´ -karbonyldiimidazolu | |
JP7205529B2 (ja) | オキサゾリジノン化合物の製造方法 | |
TW201925211A (zh) | 用於製備苯并噻吩-2-基硼酸酯之方法 | |
JPWO2016121777A1 (ja) | ピラジンカルボキサミド化合物の製造方法及びその合成中間体 | |
TW200913995A (en) | Process for the preparation of benzimidazol thienylamine compounds and derivatives thereof useful as sodium/proton exchanger type 3 inhibitors | |
AU2014221468B2 (en) | Substituted (R)-3-(4-methylcarbamoyl-3-fluorophenylamino)tetrahydrofuran-3-enecarboxylic acid (variants) and ester thereof, method for producing and using same | |
KR101811123B1 (ko) | 신규의 모르폴린 이인산염 및 이를 이용한 고순도 리바록사반의 제조방법 | |
US11414400B2 (en) | Method for preparing sulfonamides drugs | |
JP2003531146A (ja) | チアゾリジンジオン誘導体及び中間体の製造方法 | |
JP5279449B2 (ja) | 5−{4−[2−(5−エチル−2−ピリジル)エトキシ]ベンジル}−2,4−チアゾリジンジオン塩酸塩の製造方法 | |
TW201022248A (en) | Polysubstituted azetidine compounds, preparation thereof and therapeutic use thereof | |
JP6570301B2 (ja) | 4−フルオロイサチン誘導体の製造方法 | |
JP4194856B2 (ja) | 2−フェニル−4−(1−ナフチル)イミダゾール |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20211220 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20221129 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221212 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 7205529 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |